CASBIO Therapeutics joins Macquarie University’s DeepTech Incubator

We are thrilled to announce that CasBio Therapeutics has officially joined Macquarie University’s DeepTech Incubator. This strategic move will further accelerate our development of CRISPR-Cas–based diagnostics, supporting our goal of delivering rapid, sensitive, and user-friendly molecular testing at the point of care.

As part of the DeepTech Incubator, CasBio’s diagnostics research and development will benefit from advanced facilities, specialised support, and a vibrant innovation community. These resources will help us strengthen our technology pipeline and advance our transition from laboratory research toward real-world clinical and field applications.

This milestone aligns with CasBio Diagnostics’ mission to transform molecular diagnostics through CRISPR technology, enabling fast and accurate detection of pathogens for diverse human, animal, and environmental health needs.

About CasBio

CasBio is a biotechnology startup developing advanced diagnostic and therapeutic solutions powered by CRISPR and nanotechnology. The company is dedicated to translating pioneering molecular innovations into practical tools for human and animal health, with a strong focus on meaningful clinical impact. To learn more, visit https://casbio.bio.

About DeepTech Incubator

The DeepTech Incubator is Macquarie University’s specialised innovation hub supporting science-based startups advancing breakthrough technologies in biotechnology, engineering, and related fields. It offers state-of-the-art laboratory spaces, expert mentorship, and a collaborative environment designed to help early-stage companies accelerate research, scale their technologies, and bring transformative solutions to market.